Free Response to Motion - District Court of Federal Claims - federal


File Size: 357.4 kB
Pages: 50
Date: September 11, 2008
File Format: PDF
State: federal
Category: District
Author: unknown
Word Count: 10,321 Words, 65,561 Characters
Page Size: Letter (8 1/2" x 11")
URL

https://www.findforms.com/pdf_files/cofc/3690/97.pdf

Download Response to Motion - District Court of Federal Claims ( 357.4 kB)


Preview Response to Motion - District Court of Federal Claims
Case 1:03-cv-00289-FMA

Document 97

Filed 08/09/2006

Page 1 of 12

IN THE UNITED STATES COURT OF FEDERAL CLAIMS UNITED MEDICAL SUPPLY COMPANY, INC., ) ) Plaintiff, ) ) v. ) ) THE UNITED STATES, ) ) Defendant. )

No. 03-289C (Judge Allegra)

DEFENDANT'S OPPOSITION TO PLAINTIFF'S DISCOVERY MOTION Pursuant to the Court's order dated July 21, 2006, defendant, the United States, respectfully responds to the motion to compel and for sanctions filed by plaintiff, United Medical Supply Company, Inc., on July 21, 2006, as supplemented on July 31, 2006. PRELIMINARY STATEMENT 1. The Government's efficacy in preserving, gathering, and producing responsive documents in this case has been subpar and disappointing. Nothing in this brief should be construed as arguing otherwise. Among other things, too much time elapsed between the initial e-mail communications between the Defense Supply Center Philadelphia ("DSCP") and the numerous medical treatment facilities ("MTFs") in October 2002, and the point at which we began collecting documents; a very few MTFs inadvertently were not contacted in 2002 at all; and undersigned counsel for defendant delegated the document search in 2005 to an experienced professional employee of the Department of Justice who nonetheless failed to conduct a de novo search, as instructed, and who made representations upon which undersigned counsel, in turn, relied in making representations to the Court and plaintiff which we have learned were wrong. We are not attempting to excuse or explain away these regrettable circumstances.

Case 1:03-cv-00289-FMA

Document 97

Filed 08/09/2006

Page 2 of 12

2. At the same time, plaintiff's hyperbolic allegations call for a dose, if not more, of realism and perspective. United Medical submitted its certified claim to the contracting officer under the Contract Disputes Act ("CDA") in July 2002. Prior to that, there simply was no "claim" under the contract. (Approximately three months later, United Medical sold its assets to another company without making any effort to retain inventory records or other contemporaneous documents in its possession which were relevant to the claim.) The July 2002 CDA claim (attached), which was authenticated during the recent deposition de bene esse of plaintiff's former president, William Bandy, seeks damages upon four grounds: (i) diverted purchases; (ii) damage to reputation; (iii) "unpurchased stock commitments," i.e., items for which MTFs submitted "usage data," but which they did not purchase by the end of contract performance; and (iv) "early termination." There is no certified claim and, therefore, no claim properly before this Court, see 41 U.S.C. § 605, for unpaid invoices, i.e., "accounts receivable." See Pl. Mot. 3 & n.2. There is no certified claim and, therefore, no claim properly before this Court for "negligent estimates." See id. at 22-23; United Medical Supply Co. v. United States, 63 Fed. Cl. 430, 436 (2004) ("Plaintiff does not contend ­ nor does the evidence produced so far suggest ­ that the DSCP acted in bad faith in computing its estimated needs for the Lone Star Region."). And, although we recognize that the allegation might be relevant to damages, there is no certified claim and, therefore, no claim properly before this Court based upon MTFs' failure to provide "usage data." See Pl. Mot. 22. 3. Tab 1 of the affidavit of Anthony Amendolia of DSCP, filed on July 12, 2006, establishes that, beginning in October 2002, Mr. Amendolia attempted to contact individuals 2

Case 1:03-cv-00289-FMA

Document 97

Filed 08/09/2006

Page 3 of 12

(often more than one person) at every one of the 18 MTFs still operating at that time, asking the MTFs to preserve documents related to United Medical. Mr. Amendolia followed up with several more e-mails during the fall of 2002. Memories fade. However, Mr. Amendolia's e-mails constitute the best evidence of DSCP's efforts to ensure that documents were retained. At least one person who, according to an affiant, now "has no knowledge" of being contacted in 2001, Master Sergeant Rick Lester, formerly stationed at Vance Air Force Base, see Green Aff. ¶ 3, responded twice to Mr. Amendolia in November 2001, advising DSCP, "[W]e do not have any records." Amendolia Aff. Tab 4. In another instance, an affiant from Sheppard Air Force Base would in all likelihood have denied being contacted by DSCP in 2002, had he not been shown Mr. Amendolia's e-mails to him. Steele Aff. ¶¶ 5-6. The affiant from Fort Hood states that her MTF first received notice of the case in October 2005. Tyler Aff. ¶ 3. This seems unlikely, however, given that the MTF had retained responsive records dating back to 1997. Id. ¶ 4. The affiant from Tinker Air Force Base became aware of the claim on May 10, 2006. Crosby Aff. ¶ 3. However, Jennifer Howell at Tinker was notified of the claim by e-mail in 2002. Amendolia Aff. Tab 2. Consistent with this, Tinker retained prime vendor records from December 1997 forward, and non-prime vendor records starting in 1998. Crosby Aff. ¶ 7. The Air Force retention policy in effect in 2002 required these records to be kept for one year after the fiscal year in which they were created. Id. ¶ 11. Hence, there is no reason to believe substantially more responsive documents would have been available, even assuming Tinker, or the other Air Force MTFs, had been advised of the claim earlier. 4. Indeed, responsive documents from some or all of the contract term are available from 13 of the 18 ordering facilities which existed in 2002. The single largest MTF, Brooke 3

Case 1:03-cv-00289-FMA

Document 97

Filed 08/09/2006

Page 4 of 12

Army Medical Center in San Antonio, Texas, retained all of its contract records, and all of its credit card records, for the entire contract performance period. (In October 2004, this MTF mistakenly reported the documents had been inadvertently destroyed.) By agreement with plaintiff, 57 boxes (three pallets) of Brooke Army Medical Center records are currently being scanned, entirely at our expense, for production. We are also in the process of scanning 18 boxes of credit card records from 2000 and 2001 from Randolph Air Force Base, and 15 boxes of prime vendor contract and credit card records, covering virtually the entire contract term, from Tinker Air Force Base. In 2005, we produced approximately 36 CDs containing records from 1999 through 2001 from Darnall Army Hospital and Reynolds Army Community Hospital. We have also located, and are scanning for production at our expense, contract and/or credit card records covering one or more years of the contract term from the following eight MTFs: Brooks City Air Force Base; the former AMFLO II (now AMFLOA); Dyess Air Force Base; Goodfellow Air Force Base; Holloman Air Force Base; Cannon Air Force Base; Vance Air Force Base; and Kirtland Air Force Base.1 The five MTFs at which no documents were located are William Beaumont Army Medical Center; Raymond Bliss Army Hospital; Naval Hospital, Corpus Christi; Sheppard Air Force Base; and Altus Air Force Base. However, electronic credit card data for the contract term for all 18 facilities, gathered by the Department of Defense, Office of the Inspector General, were provided to plaintiff in or before June 2006. 5. United Medical argues the MTFs limited their search to credit card records and ignored other potential sources of diverted purchases, such as blanket purchase agreements
1

We realized in early August 2006 that Kirtland was inadvertently omitted from the list of ordering facilities from which we obtained affidavits. (Plaintiff has not noted this.) We are securing an affidavit from Kirtland, which we are told has 22 boxes of responsive documents. 4

Case 1:03-cv-00289-FMA

Document 97

Filed 08/09/2006

Page 5 of 12

("BPAs"). Our affiants focused upon credit card records because, prior to the production of those records, purchases diverted via credit card were the primary, if not sole, focus of plaintiff's claim and its discovery requests. In its discovery requests, plaintiff has made one parenthetical reference to "DBPAs," in a document request served in June 2005, after we began producing credit card data tending to show few diverted purchases. We reasonably understood that June 2005 request to refer to BPA purchases of DAPA items; and we know of none. In any event, we searched for BPA records. Mr. Amendolia's e-mails in the last quarter of 2002 were not limited to any specific type of non-prime vendor purchase records; and the MTFs understood the scope of the search in 2006. See, e.g., Sabroski Aff. ¶ 4 (Cannon Air Force Base searched for credit card records and "other sale purchase transactions"); Baca Aff. ¶ 9 (Dyess Air Force Base located, inter alia, BPA orders); Yuhas Aff. ¶ 9 (Goodfellow Air Force Base located, inter alia, orders placed outside the contract); Love Aff. ¶ 8 (AMFLO located BPA orders); Massey Aff. ¶ 7 (Holloman Air Force Base deemed "Local Purchases" relevant). In point of fact ­ although United Medical never asked about this during discovery ­ numerous MTFs placed few or no BPA orders and, because BPAs are administered by contracting officers, there was little or none of the diversion potential regarding DAPA items that existed with credit cards. 6. Our July 5, 2006 supplemental response to plaintiff's interrogatory number 5, about which United Medical complains, states in the second of its three sentences: "If plaintiff wishes to suggest a methodology (or alternate methodologies) for deriving estimates responsive to this interrogatory from data currently known to be available, the Government will perform the investigation and calculations necessary in order to supply the results under plaintiff's theory or theories." We have manifestly not "refused to answer." See Pl. Mot. 15. 5

Case 1:03-cv-00289-FMA

Document 97

Filed 08/09/2006

Page 6 of 12

7. We respectfully submit that, however frustrating the Government's efforts to meet our discovery obligations may have been to the Court and counsel alike, the epithet "discovery abuse" is not at all justified. See Pl. Mot. 18. ARGUMENT United Medical devotes only approximately eight of the 23 pages of its brief to the issues identified in the Court's July 21 order: "the [specific] sp[ol]iation sanctions it is seeking [and] a legal and factual analysis for their application in this case[.]" See Pl. Mot. 16-23. Plaintiff requests three forms of relief: "(1) deeming certain specified facts established, (2) compelling a prompt supplementation of the Affidavits to complete the detailed descriptions required in the Court's order of April 26, 2006, and (3) imposing monetary sanctions as the Court deems appropriate." Pl. Mot. 2-3; see id. at 22. With respect to the second request above, we respectfully defer to the Court to determine whether we have complied with its April 26 order. Should the Court determine that further steps are required in order to comply, we will take them. With respect to the first request, United Medical cites no decisions in which a court has "deem[ed] certain facts established" in circumstances such as these; that is not the remedy, even when the standard for drawing adverse inferences is met, which, here, it is not. Plaintiff's request for monetary sanctions should be denied upon the grounds, among others, that United Medical has not "explain[ed]" or supported its monetary request "in detail," as required by the order. I. There Has Been No Bad Faith Plaintiff begins by attempting to minimize and evade controlling precedent. Pl. Mot. 1617. Even assuming there is "considerable tension," as the Court stated in Klump v. United 6

Case 1:03-cv-00289-FMA

Document 97

Filed 08/09/2006

Page 7 of 12

States, 54 Fed. Cl. 167, 175 n.13 (2002), between Eaton Corp. v. Appliance Valves Corp., 790 F.2d 874 (Fed. Cir. 1986), and Sensonics, Inc. v. Aerosonic Corp., 81 F.3d 1566 (Fed. Cir. 1996), with respect to the standard for drawing adverse inferences, there is no doubt as to which is the "controlling case." See Pl. Mot. 17. When decisions of panels of the United States Court of Appeals for the Federal Circuit appear to conflict, "the precedential decision is the first." Newell Cos., Inc. v. Kenney Mfg. Co., 864 F.2d 757, 765 (Fed. Cir. 1998). Sensonics could not, and did not, overrule Eaton. See, e.g., Columbia First Bank v. United States, 58 Fed. Cl. 54, 56 (2003). Pursuant to Eaton, "the test is whether the court could draw 'from the fact that a party has destroyed evidence that the party did so in bad faith.'" 790 F.2d at 878 (quoting S.C. Johnson & Son, Inc. v. Louisville & Nashville R.R., 695 F.2d 253, 258 (7th Cir. 1982)). "If a court finds that both conditions precedent, evidence of destruction and bad faith, are met, it may then infer that the evidence would be unfavorable to the destroying party if introduced in court." Id. By its terms, this test "cannot apply" to evidence that has, in fact, been produced. Id. And, as explained in S.C. Johnson, which is quoted in Eaton, "the crucial element is not that the evidence was destroyed but rather the reason for the destruction." 695 F.2d at 258 (emphasis added); accord Klump, 54 Fed. Cl. at 175. In a reversal of the respective positions of the parties in Columbia First Bank, here, "[plaintiff] argues that [defendant's] failure to implement adequate safeguards for the documents . . . constituted bad faith. [Plaintiff] is able to point to many cases in other districts where this is the case, but none in this circuit." 54 Fed. Cl. at 703. There is absolutely no evidence, direct or circumstantial, which could support the conclusion that Government documents were destroyed by anyone in bad faith, i.e., with an intent to affect this litigation. Our failure to retain a portion 7

Case 1:03-cv-00289-FMA

Document 97

Filed 08/09/2006

Page 8 of 12

of the documents which should have been retained resulted from communications failures, inattention to detail by various individuals, and other circumstances reflecting, at most, negligence upon the Government's part. Even assuming, solely for purposes of argument, that these facts "hint[ed] at bad faith," the facts would justify no relief. Klump, 54 Fed. Cl. at 175. II. The Extreme Evidentiary Remedy Sought Is Unavailable, In Any Event Even assuming the Court determines the Eaton bad faith standard is satisfied here, United Medical points to no instance, and we know of none, in which any court has "enter[ed] a sanctions order establishing . . . controlling facts" based upon spoliation. See Pl. Mot. 22. Even when the applicable standard for spoliation is found to be satisfied, a court will, at most, draw a rebuttable adverse inference, solely with regard to the content of any missing evidence. See, e.g., Sensonics, 81 F.3d at 1573 ("[I]f evidentiary imprecision is due to inadequacy of the infringer's records, uncertainty is resolved against [it]."). And, even in such cases, "[s]ome extrinsic evidence of the content of the [missing] evidence is necessary for the trier of fact to be able to determine in what respect and to what extent it would have been detrimental." Hudson Trans. Lines, Inc. v. Zozichowski, 142 F.R.D. 68, 77 (S.D.N.Y. 1991). The focus remains, in other words, upon the evidence itself: Spoliation may provide some basis for inferring that the evidence would have been unfavorable to the party responsible; but spoliation remains only one factor in a trial court's determination, after hearing the parties' arguments, of the facts which are, or would have been, supported by the evidence. In addition to being unprecedented, plaintiff's request that the Court make a factual finding "establishing" the dollar value of the Government's requirements for items covered by the contract is not even logically supportable in this case. As noted, inferences do not substitute for 8

Case 1:03-cv-00289-FMA

Document 97

Filed 08/09/2006

Page 9 of 12

evidence. United Medical has received, or will shortly receive, at our expense, sufficient evidence, responsive to its document requests, from the large majority of the MTFs, including the single largest MTF, as well as overlapping data from the Office of the Inspector General, to develop and support at trial its own estimates of the Government's requirements and purchases. Plaintiff raises arguments concerning the comprehensiveness and weight of the records produced. See Pl. Mot. 13-15, 23. However, those are arguments for trial. Among its many other evidentiary options at trial, plaintiff can, and should, for example, compare the 57 boxes of paper credit card records being produced (as TIFF files) from Brooke Army Medical Center to the data gathered by the Office of the Inspector General for that facility, in order to test plaintiff's argument that the latter information "does not represent the universe of potential diverted purchases." See id. at 14. Plaintiff is likewise entirely free to advance at trial factual arguments based upon its extrapolations from the Fort Hood records. Id. There are by now, in fact, a surfeit of documents from the MTFs and elsewhere ­ at least 100 bankers' boxes in all, assuming electronic records are printed out ­ which neither plaintiff nor defendant is likely to be able to review in full, as opposed to relying upon sampling. This mountain of evidence cannot simply be ignored, in favor of a sweeping presumption. The volume of records which have been or will soon be produced by the Government contrasts sharply, we further note, with the fewer than eight boxes of company records, covering the entire contract term, which were produced by plaintiff in April 2005. Mr. Bandy has testified for trial that United Medical alienated possession and control of what must have been tens of thousands of pages of relevant business records in a bankruptcy sale in October 2002, several months after it retained litigation counsel and submitted its CDA claim to DSCP. 9

Case 1:03-cv-00289-FMA

Document 97

Filed 08/09/2006

Page 10 of 12

III.

Plaintiff Adduces No Support For Any Other Relief United Medical neither alleges nor adduces evidence that it has incurred attorney fees in

connection with its repetitive motions to compel. (It does not even represent that its litigation counsel, who in actuality represents the creditors of the bankruptcy estate, is compensated upon a fee basis. See Pl. Mot. 22-23.) In any event, the Government's conduct has not been obstructive or contemptuous. We have never resisted producing responsive records of the MTFs. Meanwhile, the one issue with respect to which United Medical specifically seeks supplementation of the Government's affidavits is the "outstanding receivables" claim, which this Court, as noted, lacks jurisdiction to entertain. See id. at 23. (The Government's inquiries regarding the invoices were, in any event, not performed by the MTFs, which were not involved in the payment process, see United Medical, 63 Fed. Cl. at 433, but by DSCP personnel and counsel.) Accordingly, the Court should award no monetary sanctions and no other miscellaneous relief. This case should proceed to resolution at trial, so that the parties can make their liability and damages arguments to the Court, based upon the evidence that is available. CONCLUSION For the reasons given above, we respectfully request the Court to deny plaintiff's July 31, 2006 motion in its entirety. Respectfully submitted, PETER D. KEISLER Assistant Attorney General s/David M. Cohen DAVID M. COHEN Director

10

Case 1:03-cv-00289-FMA

Document 97

Filed 08/09/2006

Page 11 of 12

OF COUNSEL: KATHLEEN HALLAM Chief Trial Attorney Defense Supply Center Philadelphia

s/Kyle Chadwick KYLE CHADWICK Senior Trial Counsel Commercial Litigation Branch Department of Justice Attn: Classification, 8th Floor 1100 L Street, N.W. Washington, D.C. 20530 Tele: (202) 305-7562 Attorneys for Defendant

August 9, 2006

11

Case 1:03-cv-00289-FMA

Document 97

Filed 08/09/2006

Page 12 of 12

CERTIFICATE OF FILING I certify that on August 9, 2006, the attached was filed electronically. I understand that service is complete upon filing and parties and others may access this filing through the Court's electronic system. s/Kyle Chadwick

12

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 1 of 38

CLAIM United Medical Supply Company, Inc., ("UMS") submits this claim for equitable adjustment and breach of contract to be made whole as a matter of right pursuant to the Contract Disputes Act of 1978. This claim arises out of a 1997 requirements contract between claimant UMS and the Defense Personnel Support Center ("DPSC"), now known as the Defense Supply Center Philadelphia ("DSCP").1 Subject to few exceptions, the contract provided that UMS would be the prime ("sole source") vendor for certain medical and surgical supplies to various Department of Defense medical facilities in the Lone Star Region, comprised of Texas, New Mexico and Oklahoma. In soliciting the contract, DSCP represented the estimated requirements, exclusive of any distribution fee to the Prime Vendor, at approximately $250 million over the base period and the four annual options. Contrary to the terms of the requirements contract and the solicitation representations made by DSCP, the actual purchases under the contract by the facilities, including a 6.4% distribution fee, were only about $30 million, or approximately eleven percent of the DSCP estimate. As discussed in detail below, the evidence is overwhelming that the supplies and equipment that contractually were required to be purchased from UMS were actually purchased from other sources. These diverted purchases breached the UMS requirements contract and entitle UMS to the damages and contract adjustments set forth in this Claim. The Lone Star Region requirements contract further provided that UMS would be paid within fifteen days from the date the government either received the invoice or the ordered supplies and equipment, whichever was later. DSCP routinely failed to make payments within the fifteen-day terms. Many payments were unjustifiably delayed for months. UMS, at the time it entered into the Lone Star Region requirements contract with DSCP, was a small business located in Fort Worth Texas. As a result of the events described in this claim, UMS filed for Chapter 11 bankruptcy and is currently being liquidated pursuant to a confirmed Chapter 11 Plan.2

For ease of reference, this agency is usually referenced by the single designation "DSCP," even though the reference may be to DPSC prior to the name change.
2

1

Appendix II, Tab 14.
Page 1

Claim - June 28, 2002

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 2 of 38

UMS submits this claim for $26,723,875.00. The components of the claim and calculation methodology are described below and in the referenced appendices. In summary, however, the claim components UMS is legally entitled to recover are lost profits of $13,919,817.00; unpurchased stock commitments of $120,540.00, damages to reputation of $11,000,000.00, and an equitable adjustment for early termination of the contract of $1,683,518.00. I. A. FACTUAL BACKGROUND

PRIME VENDOR PROGRAM

Prior to 1990 and acquisition reform, DSCP had a monopoly on sales of medical and surgical supplies to DoD facilities. Acquisition reform changed that, and the DoD facilities were permitted to seek better service, better product or lower price from the vendors of their choice.3 In response and in an effort to maintain its supply position, DSCP developed the Prime Vendor Program. (The program in which claimant UMS participated is usually referenced in this claim as the Prime Vendor Program.) In 2001, this program was replaced with the Prime Vendor II Program.4 UMS did not participate in the Prime Vendor II Program.5 Under the medical and surgical Prime Vendor Program envisioned by DSCP, there were four types of participants in the program: (1) the DSCP customer or "end-user" medical treatment facilities ("MTFs"), i.e., the DoD medical treatment facilities that purchased medical and surgical supplies and equipment, (2) DAPAholders,6 i.e., medical and surgical product manufacturers or manufacturers' representatives, including minority manufacturers' representatives (3) regional sole source distributors, or Prime Vendors ("PVs"), and (4) DSCP as Prime Vendor Program administrator.

Address by Colonel Joel Lamy, Director, Medical Material, DSCP, to the attendees of the PREPACs Conference held February 19, 1998 in Philadelphia, summarized on page 2 of the Memorandum of the meeting. Appendix II, Tab 1. PREPACs refers to "prepackaged medical procedural kits."
3 4 5 6

Sometimes called by DSCP as "GEN II" or "Generation II." UMS submitted a proposal, but its proposal was rejected by DSCP.

DAPAs, or Distribution and Pricing Agreements, are discussed in detail on the following page.
Page 2

Claim - June 28, 2002

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 3 of 38

The purchasers of medical and surgical supplies were the participating DoD medical treatment facilities. DSCP administered the program for these facilities and charged an administrative fee to each facility of approximately 1.3% of the cost of the medical and surgical supplies purchased by that facility from the Prime Vendor. Almost all the medical treatment facilities in the Lone Star Region agreed to participate in the med/surg Prime Vendor Program. One of the planned benefits of the program to the DoD was a ceiling on the cost that manufacturers of medical and surgical supplies and equipment could charge. This ceiling was the "rebated cost" of the supplies and equipment established by contracts between DSCP and the manufacturers, or manufacturers' representatives.7 These contracts, known as DAPAs, an acronym for "distribution and pricing agreements," established the "after rebate" ceiling costs for each of the products to be distributed by the Prime Vendor. The DAPAs purportedly ensured that medical and surgical products could be purchased at or near the lowest price available. When the Lone Star Regional Prime Vendor contract was awarded, DSCP had over 120,000 DAPAs in effect. Each regional Prime Vendor contractually agreed to accept orders from the facilities for all DAPA items and deliver the ordered items in accordance with the delivery terms, typically on a next business day basis, although the Prime Vendor contract provided for other shorter and longer delivery options. The Prime Vendor was required to purchase and inventory the various DAPA items and maintain a 95% fill rate for orders submitted by the facilities. The Prime Vendor also was required to provide customer support to the facilities, including periodic visits to the ordering sites. Upon receipt of an order the Prime Vendor would fill the order and include a packing slip invoice in the packing material. That packing slip included a 1.3% administrative fee charged by DSCP. The actual receivable maintained on the Prime Vendor's books excluded the DSCP administrative fee. DSCP was obligated to pay the Prime Vendor the actual receivable amount (i.e., the packing slip invoice amount less the administrative fee) within fifteen days from date of the invoice or date product was received, whichever was later.

7

The invoice cost to UMS often was more than the purchase price paid by DSCP. When the product or equipment was sold to the DoD facility, UMS would receive a manufacturer's rebate to reduce its cost to the DAPA amount. If the DoD did not promptly purchase and pay for the product or equipment, UMS could incur, and did incur, substantial costs associated with carrying either the unpurchased inventory or the delinquent account receivable.
Page 3

Claim - June 28, 2002

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 4 of 38

The Prime Vendor, in exchange for the benefits of being a sole source, assumed the burden of inventory management. As noted by Michael Schmitt, then former Program Manager of the Med/Surg Prime Vendor Program at DSCP, this burden was not light. On July 10, 1997, Michael Schmitt sent a memo to all DAPA holders detailing the burden placed on Prime Vendors to ensure that the Prime Vendor stocked only products that would be purchased by the government. Specifically, the memo advised DAPA holders that the Prime Vendor was precluded from charging the government restocking charges and the Prime Vendor was obligated to accept returns from the government for any reason. To avoid the costs of stocking unneeded supplies and equipment and to provide the effective maintenance of an inventory of 120,000 plus (and growing) DAPA items, detailed product usage data was to be provided to the Prime Vendor by the participating medical treatment facilities. DSCP contractually agreed to provide that data as part of the transition and implementation period. This claim discusses the transition and implementation period in greater detail below.

B.

THE CONTRACT SOLICITATION AND AWARD

The key solicitation and contract documents are included and tabbed in Appendix I. 1. Solicitation Summary

In 1993 the Department of Defense, through the Defense Personnel Support Center, pursuant to Solicitation DLA120-93-R-0587, invited offers from private companies to become the Prime Vendor to the Department of Defense for various medical and surgical supplies and equipment in the Lone Star Region pursuant to a requirements contract. The Solicitation was amended several times, but the contract being solicited consistently remained a requirements contract. The primary amendments were the December 1995 Amendment 008 that replaced the Initial Solicitation and the first seven (7) amendments, and Amendment 012, which, among other things, contained a discussion of the SEED (Small Entrepreneurial Enhancement Development) program and added an annual maximum purchases notice that advised Prime Vendors that the contract would be cancelled and the program re-bid if purchases under the contract exceeded an annual maximum. The Initial Solicitation, the Award, the Solicitation Amendments, and the Contract Modifications were clear with respect to the material terms of the contract being awarded. As discussed in detail below, these terms were:

Claim - June 28, 2002

Page 4

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 5 of 38

(1) A representation that a Prime Vendor requirements contract under FAR clauses 52.216-1,8 52.216-9P06, and 52.216-21 was being awarded; (2) Identification of the medical treatment facilities in the Lone Star Region that were participating in the Prime Vendor Program; (3) Identification of the medical and surgical products and supplies that were included in the award; (4) The estimated award value, calculated by DSCP in accordance with the solicitation formula; (5) DSCP's payment for supplies and equipment sold would be made within 15 days of date the product and supplies were received by the ordering facility or date of invoice, whichever was later; and (6) The contract term was a base year with four additional one-year options in favor of the government, pursuant to Clause 52.217-9P10. 2. Solicitation Discussion a) The 1993 Initial Solicitation9

The Initial Solicitation ("1993 Solicitation") represented that a Prime Vendor Program was being established and that the Prime Vendor contract would be a requirements contract, under which the Prime Vendor would be the sole source of specified classes of brand name specific and generic medical and surgical supplies and equipment. The Initial Solicitation "cautioned" that, "a requirements type contract is contemplated with the option to extend the contract for four additional one year periods.... Offers on the options are mandatory. Failure to offer on all options will result in an offer being eliminated from further consideration...."10 The government disclosed that,

8 9

Amend. 008, at 79. Appendix I, Tab 1. 1993 Solicitation at 4.
Page 5

10

Claim - June 28, 2002

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 6 of 38

Based on a 12 month reporting period, the medical treatment facilities that will be covered by the contract locally spent an estimated $27,500,000.00 per year for those types of consumable and disposable medical/surgical products and hand-held surgical instruments covered by the proposed contract.11 As described below, this estimate was substantially increased, and proposed Prime Vendors were directed to use the increased estimate to determine their offers. The government further represented in the Initial Solicitation that it would evaluate price offers by: "(1) Multiplying the annual estimated requirements for the base ordering period and each option period by the offeror's distribution fee for each period and then (2) adding the dollar figure for each year to arrive at the total cost for the distribution fee for the entire 5 years."12 The Statement of Work represented that the Prime Vendor would provide "all medical/surgical products for which the Prime Vendor has been authorized as a distributor under the [Distribution and Pricing Agreements]." The government also represented that it would provide all DAPAs to the Prime Vendor.13 The Statement of Work dealt with implementation and transition.14 The transition schedule specifically identified the facilities that would be participating in the Prime Vendor Program and provided deadlines for implementation of the Prime Vendor Program for those facilities. The deadlines specified in Attachment V varied from 60 days following the Effective Date of the Contract to 180 days.15 DSCP made a material commitment to potential offerors when it represented that "Participating facilities must provide the contractor with usage information six (6) weeks prior to start-up.... Items ordered by a facility whose usage data has not been provided or product quantities of [sic] the most recent month in question

11 12 13 14 15

1993 Solicitation at 6. 1993 Solicitation at 6. 1993 Solicitation at 7. 1993 Solicitation, SOW, at 3 and 4. Prime Vendor Program Commencement Schedule, 1993 Solicitation at 75.
Page 6

Claim - June 28, 2002

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 7 of 38

exceeding the prior 45 day usage will be exempt from the [fill rate] calculation."16 This commitment was critical to effective inventory management for several reasons, the most important being that ordered medical supplies often could not be returned to the manufacturer, if they could be returned at all, without a substantial restocking charge. Since the restocking charge could not be passed on to DSCP, it was imperative that UMS minimize ordering DAPA supplies the government would not purchase. UMS's ability to minimize the ordering of supplies not needed by DSCP was dependent on receiving accurate product usage information as contractually promised by DSCP. DSCP emphasized, "THE MINIMUM REQUIREMENTS DESCRIBED IN THE ABOVE CITED STATEMENT OF WORK REPRESENT THE MINIMUM NEEDS OF THE GOVERNMENT. ... SELECTION OF THE PRIME VENDOR WILL BE MADE BASED ON THE OFFER WHICH DEMONSTRATES THE HIGHEST PROBABILITY OF SUCCESSFUL PERFORMANCE AT A REASONABLE, REALISTIC PRICE WHERE TECHNICAL QUALITY IS MORE IMPORTANT THAN PRICE...."17 The Solicitation incorporated FAR Requirements Clause 52.216-21(c), which stated the requirements and DSCP's obligation to purchase the participating medical treatment facilities requirements from UMS. It stated, (c) Except as this contract otherwise provides, the Government shall order from the Contractor all the supplies or services specified in the Schedule that are required to be purchased by the Government activity or activities specified in the Schedule.18 Proposed exceptions to DSCP's obligations to purchase all requirements from UMS were identified in the Solicitation at pages 21, 33 and 34. The Solicitation incorporated and quoted FAR clause 52.216-9P06 which excluded from the requirements clause orders of less than $50.00.19 Proposed exclusions under FAR clause 52.216-21(e) were orders for supplies "urgently required by the Government" before the date that the Prime Vendor was

16 17 18 19

1993 Solicitation at 8. 1993 Solicitation at 15. 1993 Solicitation at 34. 1993 Solicitation at 33.
Page 7

Claim - June 28, 2002

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 8 of 38

required to make such delivery and the Prime Vendor refused the accelerated delivery.20 Proposed exclusions under FAR clause 52.216-9P13 were orders for supplies available from depot stock, routine orders which the Prime Vendor could not fill due to backorders from the manufacturer; emergency orders which could not be filled within two hours of order, and orders which were required to be filled from the Federal Prison System or certain other special programs. The Solicitation documents also provided that DSCP would not have to use the Prime Vendor to fill orders of less than $50.21 Finally, the Solicitation also incorporated FAR's Prompt Payment clause and specifically amended the clause to provide for 15-day payment under FAR 52.23525(a)(2)(i-ii).22 The Initial Solicitation addressed various other factors. It included socioeconomic provisions that UMS would be required to implement and stated that the government reserved the right to make an award for less than 100 percent of its estimated requirements.23 The government did not exercise that right. On September 14, 1993, United Medical submitted its initial proposal in response to the government's Initial Solicitation.24 The initial prime vendor contract for the Lone Star Region, however, was awarded to Owens & Minor.

b)

The 1995 Amendment 00825

On December 4, 1995, due to the failure of Owens & Minor to perform under the 1993 Solicitation, the government re-solicited offers by means of Amendment

20 21 22 23 24 25

1993 Solicitation at 34. 1993 Solicitation at 33. 1993 Solicitation at 28. 1993 Solicitation at 66. Appendix I, Tab 1. Appendix I, Tab 2.
Page 8

Claim - June 28, 2002

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 9 of 38

008.26 Amendment 008 provided that the government could accept offers in response to the Initial Solicitation and amendments 001 through 007 as an offer under Amendment 008.27 One important difference between the Initial Solicitation and Amendment 008 was the change in DSCP's representation regarding the estimated volume of medical and surgical supplies and equipment to be purchased. DSCP's representation in Amendment 008 was: Estimated Annual Requirements: Based on a 12-month reporting period, the medical treatment facilities that will be covered by the contract locally spent an estimated $57,665,500 per year for those types of medical/surgical products covered by the proposed contract. No guarantee is given that this volume will be purchased. It should be noted that during the first year of the contact [sic] each facility will begin to reduce its existing inventory of medical/surgical products. Orders will be placed with the Prime Vendor as existing inventories are reduced to lower levels This may effect the volume of ordering during the base ordering period.28 Amendment 008 incorporated FAR clauses 52.216-1 and 52.216-21 and continued the government's constant drumbeat that the contract was a requirements contract by specifically stating that the contract was a "Firm Fixed Price Requirements Contract."29 Amendment 008 further restricted the government's right to purchase from alternative sources by substituting FAR clause 52.216-9P06 for FAR clause 52.2169P13, which limited the exceptions to the government's obligation to order from

26

The performance failure of Owens & Minor is based statements made by DSCP personnel. UMS has no independent knowledge on this issue. Amend 008 at 3. Amend 008 at 12. Amendment 008, at 45, 46, and 79.
Page 9

27 28 29

Claim - June 28, 2002

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 10 of 38

UMS to either orders for less than $50.00 or emergency orders that could not be promptly filled by UMS.30 Amendment 008 additionally incorporated FAR Clause 52.217-9p14(M), which adopted the same "Evaluation of Offers" language contained in the Initial Solicitation.31 Amendment 008 gave the government the right to add or delete ordering facilities and to change the Contract Estimate based on such additions or deletions.32 During the term of the contract DSCP added two major purchasing facilities, later deleted one of those facilities (Ft. Huachuca, AZ), and deleted one minor clinic.33 The implementation and transition plan was changed to provide that the contractor would be given 120 days following the acceptance by the government of the Prime Vendor's implementation plan. The implementation plan accepted by the government required it to provide United Medical with usage data.34 Amendment 008 contained the same 15-day payment terms included in the Initial Solicitation.35

c)

DSCP's Lone Star Region Recap36

On January 17, 1996, shortly after issuing Amendment 008 to the Solicitation, DSCP provided United Medical with an 8-page written summary of the Lone Star Prime Vendor Program. Captioned, "Lone Star Region Recap," this document summarized DSCP's interpretation of the key program points. Some of the points made in the Recap relevant to this claim were:

30

Amend 008 at 45, 46. Compare page 21 of the Initial Solicitation at 21 with Amendment 008 at 45. Amend. 008 at 12 and 89. Amend. 008 at 13.

31 32 33

The largest added purchasing facility was AFMLO/OL-2, Ft. Worth, Texas, with estimated annual purchases of $400,000.00. Appendix I, Tabs 6 and 7. Amend. 008 at 27. Amend. 008 at 40. Appendix I, Tab 3.
Page 10

34 35 36

Claim - June 28, 2002

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 11 of 38

Estimated [Annual] Sales: $57,655,500.00 (Initial year may be lower due to Inventory reduction.) Facility Cost: + + Minimum Order: Payment: DAPA/IDTC Price PV Fee (%) 1.3% = DPSC Fee $50.00

15 days Via Electronic Funds Transfer (EFT)

Commence performance not later than 120 days after approval of plan. (If first PV award.) Implementation time based on government providing usage data to PV within 10 days of award. Facility will reduce on-hand stock during transition period.

d)

The 1996 Amendment 001237

DSCP issued Amendment 0012 on February 7, 1996. UMS submitted its offer on the form and in accordance with the terms and requirements contained in Amendment 0012. The material terms on which UMS relied in making its offer were carried forward from Amendment 008. Amendment 0012 contained a provision for yearly maximums, which were approximately 210% of the estimated yearly purchases. The effect of the yearly maximums was to notify the Prime Vendor that if purchases under the contract exceeded any yearly maximum, the contract would be re-bid for the next year. P. 5. Amendment 0012 incorporated and quoted in full the clause 52.217-9P10, "OPTION FOR REQUIREMENTS CONTRACT TERM EXTENSION (PRIME VENDOR)." The option was a one-way option solely in favor of DSCP. Amendment 0012 reiterated that the annual purchase volumes were estimated to be $57,982,750.00 after the initial year and directed the offerors to rely on this estimate. Specifically, the government stated:

37

Appendix I, Tab 4.
Page 11

Claim - June 28, 2002

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 12 of 38

Based on a 12-month reporting period, the ordering facilities that will be listed in Attachment III spent an estimated $57,965,500 per year for those types of medical/surgical products covered by the proposed contract. Based on this figure, the following is the Government's best estimate of yearly sales that the ordering facilities will experience over the five year period.38

Yearly Estimate First Year Second Year Third Year Fourth Year Fifth Year $ 28,982,750.00 57,965,500.00 57,965,500.00 57,965,500.00 57,965,500.00

Approximately Yearly Maximum $ 72,456,875.00 144,913,750.00 144,913,750.00 144,913,750.00 144,913,750.00

Following the above table providing the purchase estimates, Amendment 0012 further emphasized that the offer should be based on these estimates and instructed offerors that, "Your proposed distribution fee should be based on the Yearly Estimate...."39 In Amendment 0012, DSCP provided a calculation example of how offers would be evaluated. That calculation again represented that the annual estimates did not include any distribution fee.40

38 39 40

Amend. 0012 at 5. Amend. 0012 at 5. Amend. 0012 at 7 and 8.
Page 12

Claim - June 28, 2002

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 13 of 38

C. 1.

UNITED MEDICAL SUPPLY COMPANY, INC. AND ITS PROPOSAL Background of United Medical Supply

United Medical Supply Company was established in Fort Worth, Texas in 1980 as a Texas corporation. It enjoyed a 21-year history as a reputable regional distributor of medical supplies to various governmental entities and private industry. It typically employed about 150 employees and numerous other independent contractors and small businesses. Its annual revenues, exclusive of the Lone Star Region Prime Vendor contract, grew to approximately $60 million.41 In sum, UMS was a reputable and responsible corporate citizen in the Fort Worth community. Throughout its 21-year history United Medical was a small business whose only business was distribution of medical supplies and equipment to hospitals, physicians and other medical providers on a regional basis. It enjoyed an excellent reputation. Its tenure in the business and the fact that it was selected to be the Lone Star Region's Prime Vendor is substantial evidence of that good reputation. Moreover, UMS's reputation, at one time, was one of the most outstanding in the industry. In September 2000, Repertoire, a national publication of Medical Distribution Solutions, Inc., published survey results from an earlier independent Physicians World Class Survey.42 Respondents to that survey included physicians and various medical treatment facilities. Five classes of distributors were evaluated: national, regional, local, specialized and direct marketing. The evaluations were based on sixteen criteria. Based on those sixteen criteria, UMS was rated the best regional distributor in the United States and fourth highest overall distributor out of the 567 distributors evaluated. UMS's rating of 96.84 percent was higher than any national or other regional distributor. Only three local distributors had higher ratings. As a result of the events described in this claim, UMS ran into severe credit problems in 2000 and ultimately filed for Chapter 11 bankruptcy protection in March 2001. Shortly before the time it initially encountered these credit problems, UMS had received buyout offers in the $10 million range, which are discussed in more detail below. Naturally, the Chapter 11 proceedings slammed shut the door of reasonable buyout possibilities. UMS currently is being liquidated pursuant to a confirmed Chapter 11 plan.

41 42

Appendix III, Tabs 1 ­ 3. Appendix II, Tab 2.
Page 13

Claim - June 28, 2002

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 14 of 38

2.

UMS's Reliance on the Solicitation Documents and its Decision to Offer

UMS read carefully the Solicitation and amendments when received. Amendments 008 and 0012 contained the offer forms and terms on which UMS submitted its offer. They contained various material terms, including: (1) "The prime vendor SEED concept [was] an attempt to ensure growth opportunities and participation of small business and small disadvantaged business concerns in the Prime Vendor Program."43 "A requirements type contract [was] contemplated with the option to extend the effective period of the contract for four additional one year periods."44 Estimated yearly requirements were based on previous usage as reported by the facilities. The estimates, exclusive of distribution fees, were for $28,982,750 in year one and $57,965,000 each year thereafter. UMS was instructed to propose a distribution fee based on these estimates.45 The government's right to purchase supplies and equipment from third party sources, i.e., not UMS, was limited to orders under $50 and emergency orders UMS could not fill.46 The DAPA listing of products included in the requirements contract was estimated to include an initial 122,000 medical and surgical items and to grow to 500,000 items.47 Payment to UMS would be by EFT in 15 days from the later of the date the invoice was received or the date the goods were delivered.48

(2)

(3)

(4)

(5)

(6)

43 44 45 46 47

Amend. 0012 at 3. Amend. 008 at 5; Amend. 0012 at 4. Amend. 0012 at 5. Amend. 0012 at 33. Amend. 0012 at 14. UMS actually loaded 190,000 DAPA items into its database.
Page 14

Claim - June 28, 2002

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 15 of 38

As previously discussed in this claim, the potential sales volume and prompt payment terms were extremely appealing to and relied on by UMS both in making a decision to respond to the Solicitation and in calculating its proposed distribution fee. The importance of the contract size is evident. It would almost double the annual revenues of UMS. In responding to the Solicitation, United Medical spent hundreds of hours preparing its offer and amendments. It confirmed with both Michael Schmitt ­ then Program Manager, Med/Surg Prime Vendor, Directorate of Medical Materiel and Margaret Rees, his supervisor and then Chief of Medical/Surgical Products Group -- that the Lone Star Region would produce the volume of sales revenues estimated in the Solicitation and that that invoices submitted by United Medical would be paid within the 15 day contractual period. Shortly after the award, but before the effective date, UMS confirmed with Linda Flatley, then Chief, New Initiatives Section and the contracting officer, that UMS could rely on the requirements representations and terms of the solicitation and contract. Prompt payment of invoices was essential to UMS. The Solicitation and contract represented that DSCP would pay each invoice within fifteen days of receipt of the invoice or, if later, delivery of the product. UMS relied on the accuracy of that representation in preparing its offer and calculating its projected cash flow and future cash needs. The projected profits estimated by UMS through the Prime Vendor Program were reasonable, but, like UMS's cash needs, they were very much tied to 15-day payment by DSCP. The DSCP estimates could not be met by UMS without timely payment in accordance with the terms of the contract. UMS, as a small business, did not have the internal financial capability to fund the projected sales growth. It sought and obtained a substantial line of credit to be used on an emergency basis, but the primary source of funds necessary to sustain the projected sales was DSCP, and prompt payment was as necessary as the size of the payment. Also critical to UMS was accurate and complete product usage data. As a small business, UMS could not risk inventorying products the ordering facilities seldom or never purchased, or inventorying too much of given products. The primary tool for avoiding these problems was accurate and complete product usage data that, pursuant to the contract, was to be supplied by DSCP or the medical treatment facilities.

48

Amend. 008 at 40. UMS's practice was to electronically invoice DSCP when the order was shipped.

Claim - June 28, 2002

Page 15

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 16 of 38

The Solicitation documents and repeated discussions with DSCP personnel assured UMS that it could rely on the Solicitation documents, especially in the volume, payment terms and product usage data representations of DSCP. If UMS had had any significant reservations in these areas, it would not have submitted an offer. United Medical would not have submitted its offer but for the fact that the contract being awarded was a requirements contract for purchase volumes represented by DSCP been represented as substantial, that payment for the purchases would be made within fifteen days of invoice or product delivery, and that the DoD would provide accurate product usage data. The UMS decision to submit an offer and its proposed distribution fee were premised on these representations. 3. Distribution Fee Proposed

UMS, in total reliance on the material representations by DSCP, submitted its offer on February 26, 1996, and proposed a distribution fee of 6.4% of the DAPA cost of the supplies and equipment sold under the contract. UMS projected its profits and cash flows on the material representations and determined that a 6.4% distribution fee for the volume estimated by DSCP paid within fifteen days of invoice would yield a reasonable profit. UMS took into account the risk that the requirements of the ordering medical treatment facilities might not reach the DSCP projections. UMS considered this unlikely because the estimated volumes were purportedly based on historical usage volumes and DSCP had represented that the DAPA product list was projected to grow from 122,000 items to 500,000. Nevertheless, because of the significant consequences to UMS if the estimated sales volume was not achieved, it protected itself against this contingency by including in its offer a contract condition requiring renegotiation of the distribution fee if the requirements did not reach at least 90 percent of the stated contract award.49 The offer proposal offered by UMS was accepted by DSCP as written, including the right to the renegotiated distribution fee described above.

49

Response to Amend. 0012 at 2. Appendix I, Tab 4. This right to a renegotiation was carried forward from UMS's response to Amend. 008 at 6. Appendix I, Tab 2.
Page 16

Claim - June 28, 2002

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 17 of 38

D.

THE CONTRACT AWARD AND MODIFICATIONS50

On January 30, 1997, and over the protest of two national distributors who had submitted competing offers, Claimant United Medical was awarded Prime Vendor contract number SP0200-97-D-7133 effective June 1, 1997, consistent with the solicitation. The Award, signed by Linda Flatley as the Contracting Officer, assigned an "Estimated Dollar Value for the Base Year of $30,177,346.00 and an Estimated Total Contract Value of $272,268,314.00.51 The award also incorporated the Solicitation Terms into the Contract and specifically identified the 32 ordering (i.e., purchasing) governmental units that were participating in the Lone Star Region's Prime Vendor Program. Block 18 of the Award incorporated the terms of the UMS offer as follows: Your offer on Solicitation Number DLA120-93-R-0587, including the additions or changes made by you which additions or changes are set forth in full above is hereby accepted as to the items listed above and on any continuation sheets. This award consummates the contract which consists of the following documents: (a) the Government's solicitation and your offer, and (b) this award/contract. No further contractual document is necessary. Bolding added. Under this term of the award, incorporated into the contract and accepted by DSCP was the right of UMS right to a renegotiated fee if DSCP's requirements did not equal at least 90% of the DSCP requirements estimate. Shortly after the award, Brooke Army Medical Center, one of the participating facilities in the Lone Star Region Prime Vendor Program, raised an issue concerning its obligations to purchase DAPA products solely from UMS. UMS was concerned about making capital investments if the contract was not a requirements contract. It immediately requested confirmation for DSCP that the award was for a requirement contract and that the obligations were absolute. See footnote 52. On March 4, 1997, it received that confirmation from Linda Flatley, contract officer and then Chief, New Initiatives Section. She stated in response:
United Medical should not be reluctant to invest in capital commitments, but should proceed with full implementation as quickly as possible. Colonel

50 51

Appendix I, Tabs 5 ­ 11. Award at 1.
Page 17

Claim - June 28, 2002

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 18 of 38

McNabb, as well as DPSC, will provide complete support during the transition period and beyond.52

Following the award, there were several subsequent material modifications to the contract. Modification No. 5, effective June 18, 1997, committed DSCP to alternative dispute resolution at any stage of a dispute; Modification No. 6, effective June 30, 1997, added AFMLO/OL-2, Ft. Worth, TX, as a purchasing facility with estimated annual purchases of $400,000.00.53 Modification No. 10 signed by Linda Flatley for DSCP on May 27, 1998, effective June 1, 1998, exercised option year 1.54 Modification No. 16 signed by James Jenning for DSCP on May 11, 1999, effective June 1, 1999, exercised option year 2.55 Modification number 21 signed by Donna Kennedy for DSCP on May 22, 2000, effective June 1, 2000, exercised option year 3.56 Modification No. 26 terminated the contract effective April 30, 2001.57 The ostensible reason given by DSCP for the termination was that it was implementing the Prime Vendor II Program. E. 1. UMS POST AWARD PERFORMANCE The Transition and Implementation Period

The contract discussed, in detail, transition and implementation. In summary, the transition and implementation period was a 120-day period beginning when the government approved the UMS implementation plan. Primary transition and implementation activities included: software installation, training on software use, evaluation of usage data to be provided by the government,

52 53 54 55 56 57

Appendix II, Tab 3. Appendix I, Tabs 6 and 7. Appendix I, Tab 8. Appendix I, Tab 9. Appendix I, Tab 10. Appendix I, Tab 11.
Page 18

Claim - June 28, 2002

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 19 of 38

attempted verification of usage data provided by the government, and data input for approximately 190,000 DAPA items. From UMS's standpoint, the most important transition objective it needed accomplished was receipt of complete and accurate product usage data for the participating facilities, as promised in the Solicitation and Award. DSCP had ultimate responsibility for this obligation. As discussed elsewhere, DSCP did not faithfully discharge this obligation and UMS never obtained accurate and complete product usage data, although UMS devoted an inordinate amount of manpower attempting, unsuccessfully, to obtain this data from the participating medical treatment facilities and the former Prime Vendor, Owens & Minor. 2. Post Transition Period a) UMS Performance

To ensure that adequate inventory could be housed and that deliveries would be timely, UMS added warehouse space -- including a new 32,000 square foot facility in El Paso Texas, a 16,000 square foot addition to the San Antonio warehouse, and special climate controlled warehouse sections in Fort Worth and El Paso. It purchased substantial computer hardware and software to handle the ordering and invoicing process demanded by the government. Its fill rates typically were in excess of the 95% contract specification. On occasion the lack of accurate and complete usage data and other problems at the ordering facility prevented a 95% fill rate. When the government notified UMS of problems, either with an ordering facility or with DSCP, UMS responded promptly and professionally to resolve the problem. Eventually DSCP terminated the contract early by means of modification 26, which terminated the contract in April 2001, just before the end of the third option year. The reason given by DSCP was that it was implementing Prime Vendor II. The contract was not terminated for any performance problems attributable to UMS; the government did not attempt to hold back any payments due UMS as damage offsets; and the government did not alleged that it suffered damages from any breach by UMS. To the contrary, as discussed below, the government periodically admitted that it failed to perform its obligations under the contract and told UMS that it was pleased with its performance as a Prime Vendor. When UMS was awarded the contract, it prepared to supply the DoD approximately $300 million of medical and surgical products and supplies over a five-year period. The DoD estimate of product it would purchase, as modified by

Claim - June 28, 2002

Page 19

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 20 of 38

Modification 006 to the award, was $274,268,214.00. DSCP actually purchased approximately $31,000,000 of products and supplies, or about eleven percent of the DSCP estimated contract volume.58

F.

DSCP CONDUCT AND BREACH

The Lone Star Region Prime Vendor contract was a disaster for United Medical Supply. The disaster began during the transition period when UMS was not able to get accurate and usable product usage data from the government. The disaster continued when the Government ordering facilities diverted most of their product and supply purchases from UMS to other sources and when the payments due UMS for product actually purchased often were delayed substantially beyond the 15 day period specified in the contract.

1.

Breach by Diversion of Purchases

The government's diversion of purchases away from the UMS contract was the most egregious breach by the government. The evidence of diversion is undeniable and compensable. See, T&M Distributors, Inc., ABSCA No. 51,279, 2001 WL 638522, 01-2 BCA ¶31,442.59 Standing alone, the dramatic disparity between the DSCP estimates and actual purchases provides compelling evidence that substantial diversion occurred. The government cannot argue in good faith that the actual purchases of a small fraction of the estimate were due to reduced requirements by the government. Such an argument would make a mockery of the estimates and the March 4, 1997 Flatley directive to UMS that UMS should not be reluctant to invest in capital commitments. This disparity is shown simply in the charts on the next page.

58

UMS's records indicate that immediately prior to filing its Chapter 11 petition, the actual volume purchased from UMS by DSCP over the 47-month contract period was $31,869,516.19. Appendix III, Tab 5. T&M Distributors opinion attached at Appendix II, Tab 20. References to specific opinion pages refer to the page numbers of the format as printed in the Appendix.
Page 20

59

Claim - June 28, 2002

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 21 of 38

TABLE I Comparison of Estimated Dollar Volume of Purchases with Actual Dollar Volume of Purchases (Millions of $$)

Base Year DSCP Estimated Purchases, (including facility added by Mod 006) (millions $) Approximate Actual Purchases (millions $)

Option Year 1

Option Year 2

Option Year 3

Option Year 4

Totals

30.4

60.9

60.9

60.9

60.9

274.0

6.4

8.4

10.6

6.5

0.0

31.9

TABLE II Percentage of Actual Dollar Volume of Purchases to Estimated Dollar Volume of Purchases

Base year % Actual/ Estimated (including option yr. 4) % Actual/ Estimated (excluding option yr. 4)

Option Yr. 1

Option Yr. 2

Option Yr. 3

Option Yr. 4

Total

21.0%

13.8%

17.4%

10.7%

0.0%

11.6%

21.0%

13.8%

17.4%

10.7%

n/a

15.0%

Claim - June 28, 2002

Page 21

Case 1:03-cv-00289-FMA

Document 97-2

Filed 08/09/2006

Page 22 of 38

Additionally, there are at least two documents in which DSCP or its representatives admit that diversions occurred. Both blame the problem on the use by the medical treatment facilities of government credit cards. The first is a 1999 predecessor to the DSCP 2000 Prime Vendor II Solicitation. In an Addendum to Solicitation SP0200-99-5003, DSCP recognized that its "sole source" obligations of Prime Vendor I (the UMS program) were not met. DSCP does not disclose in the SP0200-99-R-5003 Solicitation that the failure to meet these obligations was attributable to its own mismanagement. In the Solicitation SP0200-99-R-5003, DSCP summarized the history of the Prime Vendor Program in which UMS had participated and stated, "Currently DSCP's PV Med/Surg contract sales worldwide are averaging eight million four hundred thousand dollars per month. The MTF's [Medical Treatment Facilities] estimate the balance of Med/Surg items are purchased directly from manufacturers and dealers using government wide commercial purchase cards and/or local purchase methods. It can be assumed the percentage of DSCP Med/Surg PV sales to total Med/Surg sales is relatively consistent across regions. DSCP PV Medical/Surgical sales worldwide were $69.3 million and $97.5 million for fiscal years 1997 and 1998 respectively."60 Emphasis added. Even after disclosure in the SP0200-99-R-5003 solicitation that purchasing organizations were not complying with the sole source requirement of the Prime Vendor Program, DSCP continued to emphasize that the Prime Vendor Program was a sole source program. On January 13, 2001, too late to help UMS, the government published a Prime Vendor Program Overview in DEFENSE MEDICAL MATERIAL ONLINE.61 The Overview featured the benefits of the Prime Vendor Program, including "Best Overall Pricing in the Industry," "Lowest Delivered Cost of an Item," "Lower